Cargando…

SKA1/2/3 serves as a biomarker for poor prognosis in human lung adenocarcinoma

BACKGROUND: Spindle and kinetochore associated complex subunit 1/2/3 (SKA1/2/3), which stabilized spindle microtubules attaching to kinetochore (KT) in the middle stage of mitosis, were dysregulated, and closely related to prognosis in several malignant tumors. Nevertheless, the potential clinical v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Cheng, Guo, Qiang, Song, Yongxiang, Xu, Gang, Liu, Lunxu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225159/ https://www.ncbi.nlm.nih.gov/pubmed/32420061 http://dx.doi.org/10.21037/tlcr.2020.01.20

Ejemplares similares

SKA3 Serves as a Biomarker for Poor Prognosis in Kidney Renal Papillary Cell Carcinoma
por: Feng, Dechao, et al.
Publicado: (2021)

SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma
por: Song, Guo-Qiang, et al.
Publicado: (2022)

Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
por: Niu, Cong, et al.
Publicado: (2022)

SKA3 Up-regulation Promotes Lung Adenocarcinoma Growth and is a Predictor of Poor Prognosis
por: Sun, Rong-Li, et al.
Publicado: (2019)

FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
por: Yu, Yilin, et al.
Publicado: (2021)

Overexpression of SKA Complex Is Associated With Poor Prognosis in Gliomas
por: Yu, Shoukai
Publicado: (2022)

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
por: Chen, Yibing, et al.
Publicado: (2018)

Integrative Multi-Omics Analysis of Identified SKA3 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma
por: Lin, Yuansheng, et al.
Publicado: (2022)

Overexpression of SKA3 correlates with poor prognosis in female early breast cancer
por: Zhong, Yue, et al.
Publicado: (2021)

ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma
por: Yang, Hai-deng, et al.
Publicado: (2023)

SKA3 promotes lung adenocarcinoma metastasis through the EGFR–PI3K–Akt axis
por: Hu, Dan-dan, et al.
Publicado: (2020)

Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

SKA3 overexpression predicts poor outcomes in skin cutaneous melanoma patients
por: Pang, Hao, et al.
Publicado: (2021)

BRCA1/2 Serves as a Biomarker for Poor Prognosis in Breast Carcinoma
por: Jin, Tong Yi, et al.
Publicado: (2022)

The SKA and its Computing Challenges
por: Deegan, Miles
Publicado: (2018)

Aurora B is no Ska fan
por: Leslie, Mitch
Publicado: (2012)

CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma
por: Wang, Xueying, et al.
Publicado: (2022)

SKA3 is a prognostic biomarker and associated with immune infiltration in bladder cancer
por: Wang , Chenyang, et al.
Publicado: (2022)

Ska3 Ensures Timely Mitotic Progression by Interacting Directly With Microtubules and Ska1 Microtubule Binding Domain
por: Abad, Maria Alba, et al.
Publicado: (2016)

Lung adenocarcinoma initially mimicking localized emphysema
por: Cheng, Jiahan, et al.
Publicado: (2020)

High CTSL2 expression predicts poor prognosis in patients with lung adenocarcinoma
por: Song, Junnian, et al.
Publicado: (2021)

Stable kinetochore–microtubule interactions depend on the Ska complex and its new component Ska3/C13Orf3
por: Gaitanos, Thomas N, et al.
Publicado: (2009)

Integrated analysis of SKA1-related ceRNA network and SKA1 immunoassays in HCC: A study based on bioinformatic
por: Zeng, Fanjing, et al.
Publicado: (2023)

Forecasting Sales at Ska Brewing Company
por: Drake, Matthew
Publicado: (2014)

Macar ska förhindra jordens undergång
Publicado: (2008)

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma
por: Fan, Yongfei, et al.
Publicado: (2022)

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
por: Tan, Jianlong, et al.
Publicado: (2022)

The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma
por: Chen, Aifeng, et al.
Publicado: (2021)

High SERPINH1 expression predicts poor prognosis in lung adenocarcinoma
por: Zhang, Hailing, et al.
Publicado: (2022)

DDIT4 overexpression associates with poor prognosis in lung adenocarcinoma
por: Song, Li, et al.
Publicado: (2021)

Structural basis for microtubule recognition by the human kinetochore Ska complex
por: Abad, Maria Alba, et al.
Publicado: (2014)

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma
por: Gao, Wen, et al.
Publicado: (2022)

SIRT1 expression is associated with poor prognosis of lung adenocarcinoma
por: Li, Chong, et al.
Publicado: (2015)

SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma
por: Zhang, Xiuao, et al.
Publicado: (2022)

CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis
por: Yu, Senlong, et al.
Publicado: (2023)

Claudin‐1 correlates with poor prognosis in lung adenocarcinoma
por: Sun, Bing‐sheng, et al.
Publicado: (2016)

SLC15A4 Serves as a Novel Prognostic Biomarker and Target for Lung Adenocarcinoma
por: Huang, Hui, et al.
Publicado: (2021)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

H r ska universums hemligheter avslöjas
Publicado: (2009)

Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma
por: Yang, Jian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u9uu6i3kmfo05p8uf8kk0671dp